10 recruiting. 10 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Recruiting 10 |
| Phase 3 | 1 | Recruiting 1 |
Follow Surgery: new trials by email Literature Review of Surgery trials Research Report on Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Primary Tumor Resection and Selective Lymph Node Dissection Followed by RT for BTC With Lymph Node Metastases Primary Tumor Resection and Selective Lymph Node Dissection, Postoperative Radiotherapy, Capecitabine or S-1 - Biliary Tract Cancer (BTC), Surgery | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 73 | 2026-10-08 | 2026-10-26 |
| Use of Corticosteroid in Intraopertive Injections in Total Knee Replacement Surgery. PAI, PAI + steroid, PAI + zilretta - Knee Osteoarthritis, Musculoskeletal Disease | Phase 2 / Phase 3 | Recruiting | Walter Reed National Military Medical Center | 240 | 2026-09-01 | 2026-08-19 |
| Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery FEIBA, FFP - Cardiac Disease, Surgery | Phase 2 | Recruiting | Northwell Health | 140 | 2025-11-03 | 2026-03-11 |
| Prevent Cardiac Surgery Associated AKI Trial CoQ10 1200 mg orally with Glutathione 1000 mg orally, Group B: Placebo CoQ10 orally and Placebo Glutathione orally - Renal Failure, Coronary Artery Disease | Phase 2 | Recruiting | George Washington University | 242 | 2024-07-18 | 2026-10-14 |
| Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab - Lung Cancer, Surgery | Phase 2 | Recruiting | Second Affiliated Hospital of Guangzhou Medical University | 90 | 2024-07-01 | 2024-07-09 |
| Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma. ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab - Hepatic Cancer, Surgery | Phase 2 | Recruiting | Second Affiliated Hospital of Guangzhou Medical University | 90 | 2024-07-01 | 2024-07-09 |
| Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer Cardonilizumab, Chemoradiotherapy ±immunotherapy, Radical surgery - Esophageal Cancer, Immunotherapy | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 60 | 2024-05-01 | 2025-05-30 |
| Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. Propranolol, Placebo - Pancreatic Cancer, Surgery | Phase 2 | Recruiting | Zealand University Hospital | 30 | 2024-03-20 | 2024-03-28 |
| Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery Early rehabilitation through Adapted Physical Activity - Oncology, Elderly Patients | Phase 2 | Recruiting | Centre Francois Baclesse | 60 | 2024-03-15 | 2026-01-12 |
| Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma Thyroxine - Thyroid Cancer, Surgery | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 140 | 2022-08-01 | 2023-10-17 |
Biliary Tract Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Coronary Artery Disease (1) · Esophageal Neoplasms (1) · Heart Diseases (1) · Hemorrhage (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Lymphatic Metastasis (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Osteoarthritis, Knee (1) · Pancreatic Neoplasms (1) · Recurrence (1)
Neoplasms (6) · Neoplasms by Site (6) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cardiovascular Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Head and Neck Neoplasms (2) · Adenocarcinoma (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Arthritis (1) · Biliary Tract Diseases (1)
Bevacizumab (2) · Idarubicin (2) · Ipilimumab (2) · durvalumab (2) · pembrolizumab (2) · Capecitabine (1) · Glutathione (1) · Methylprednisolone (1) · Propranolol (1) · S 1 (combination) (1) · Steroids (1) · Thyroxine (1) · Triamcinolone (1) · anti-inhibitor coagulant complex (1) · coenzyme Q10 (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (3) · Second Affiliated Hospital of Guangzhou Medical University (2) · Centre Francois Baclesse (1) · George Washington University (1) · Northwell Health (1) · Walter Reed National Military Medical Center (1) · Zealand University Hospital (1)
China (5) · United States (3) · Denmark (1) · France (1)
Zhenfeng Zhang, MD, PhD (2) · John P Cody, MD (1) · Pey-Jen Yu (1) · Xin Wang (1) · Yoosif Abdalla, MD (1)
PMID 18306479, PMID 30203101, PMID 30234517, PMID 31155459, PMID 31516975, PMID 31806506, PMID 31839089, PMID 33482865, PMID 35123474, PMID 37071876, PMID 38282804, PMID 38380215, PMID 38876084, PMID 38919978